|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 38/22 | |
| A61K 31/573 | |||
| A61P 29/00 | |||
| A61P 11/06 | |||
| A61P 11/00 | |||
| A61P 37/00 |
| (11) | Number of the document | 2533799 |
| (13) | Kind of document | T |
| (96) | European patent application number | 11740491.3 |
| Date of filing the European patent application | 2011-02-07 | |
| (97) | Date of publication of the European application | 2012-12-19 |
| (45) | Date of publication and mention of the grant of the patent | 2019-11-20 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2011/023917 |
| Date | 2011-02-07 |
| (87) | Number | WO 2011/097571 |
| Date | 2011-08-11 |
| (30) | Number | Date | Country code |
| 201113021950 | 2011-02-07 | US | |
| 302325 P | 2010-02-08 | US |
| (72) |
DU, Tao, Tom, US
|
| (73) |
Shenzhen Evergreen Therapeutics Co., Ltd.,
62 Guimiao Road, Shuntian Tower, Suite 14A Shenzhen, Guangdong Province,
CN
|
| (54) | METHODS FOR THE USE OF PROGESTOGEN AS A GLUCOCORTICOID SENSITIZER |
| METHODS FOR THE USE OF PROGESTOGEN AS A GLUCOCORTICOID SENSITIZER |